drugset / Trial / NCT07400965
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-masked, placebo-controlled, dose-ranging, parallel-group, multi-center study designed to evaluate the safety and efficacy of GLK-321 in patients with Demodex blepharitis.
Timeline
- Start
- 2025-12-05
- Primary completion
- 2026-09
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLK-321 | Unknown | — | — |